The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk

NCT ID: NCT01019499

Last Updated: 2010-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effects of berry consumption on indicators of cardiovascular disease risk (blood pressure, cardiovascular biomarkers, nutrigenomics).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study has a randomized crossover design. It consists of two 8-wk dietary treatments, with no washout period between periods. The participants are blinded to treatments. The subjects are randomly assigned to either a berry diet or a control diet which they follow for 8 weeks. After that they are crossed over to the other diet for another 8 weeks. The main visits to the study site are at baseline and after 8 and 16 weeks (for blood pressure measurement/ cardiovascular measurements and sample collection). The additional visits are at 4 and 12 wk; these visits are for compliance checks, meeting the study nurse and receiving the study products. The subjects are asked to maintain their normal dietary and lifestyle habits, as well as to keep alcohol intake and physical activity constant during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure Platelet Function Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

berry products

Berry products

Group Type ACTIVE_COMPARATOR

berry products

Intervention Type OTHER

effects of berry consumption on cardiovascular indicators

two portions daily

control products

Control products

Group Type PLACEBO_COMPARATOR

control products

Intervention Type OTHER

two portions daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

berry products

effects of berry consumption on cardiovascular indicators

two portions daily

Intervention Type OTHER

control products

two portions daily

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* mild hypertension (systolic blood pressure 130-159 mmHg, diastolic blood pressure 85-99 mmHg)

Exclusion Criteria

* smoking
* regular use of medications (except hormone replacement therapy) or dietary supplements
* intestinal disorders
* obesity (BMI\> 35 kg/m2)
* vegetarianism
* pregnancy
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agrifood Research Finland

UNKNOWN

Sponsor Role collaborator

The Finnish Funding Agency for Technology and Innovation (TEKES)

OTHER_GOV

Sponsor Role collaborator

Academy of Finland

OTHER

Sponsor Role collaborator

University of Oslo

OTHER

Sponsor Role collaborator

Finnish Institute for Health and Welfare

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

National Institute for Health and Welfare

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antti Jula, DR.

Role: STUDY_DIRECTOR

Finnish Institute for Health and Welfare

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institute for Health and Welfare

Helsinki, Helsinki, Finland

Site Status

National Institute for Health and Welfare

Turku, Turku, Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NPHIKTL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Water-Blueberry Study
NCT00520871 COMPLETED PHASE1/PHASE2